methyllycaconitine has been researched along with rubidium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crooks, PA; Dwoskin, LP; Grinevich, VP; Miller, DK; Norrholm, SD; Zheng, G | 1 |
Crooks, PA; Deaciuc, AG; Dwoskin, LP; Sumithran, SP; Wilkins, LH; Xu, R; Zhu, J | 1 |
2 other study(ies) available for methyllycaconitine and rubidium
Article | Year |
---|---|
Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
Topics: Aconitine; Animals; Biological Transport; Carrier Proteins; Cells, Cultured; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Ganglionic Stimulants; Humans; Iodine Radioisotopes; Kinetics; Lobeline; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Nicotine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Rubidium; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2004 |
Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
Topics: Aconitine; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Design; Drug Evaluation, Preclinical; Electric Stimulation; Humans; Male; Molecular Structure; Nicotine; Nicotinic Antagonists; Nomifensine; Protein Binding; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Rubidium; Structure-Activity Relationship; Synaptosomes | 2005 |